• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实体瘤中的癌症干细胞:综述

Cancer stem cells in solid tumors: an overview.

作者信息

O'Brien Catherine Adell, Kreso Antonija, Dick John E

机构信息

Department of General Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

出版信息

Semin Radiat Oncol. 2009 Apr;19(2):71-7. doi: 10.1016/j.semradonc.2008.11.001.

DOI:10.1016/j.semradonc.2008.11.001
PMID:19249644
Abstract

It has long been appreciated that significant functional and morphologic heterogeneity can exist within the individual cells that comprise a tumor. Increasing evidence indicates that many solid tumors are organized in a hierarchical manner in which tumor growth is driven by a small subset of cancer stem cells (CSCs) or tumor-initiating cells. Although these cells represent a small percentage of the overall tumor population, they are the only cells capable of initiating and driving tumor growth. Emerging evidence indicates that these cells are also resistant to chemotherapy and radiation therapy, which has led to much speculation and interest surrounding the potential clinical applicability of CSCs.

摘要

长期以来,人们已经认识到,构成肿瘤的单个细胞内可能存在显著的功能和形态异质性。越来越多的证据表明,许多实体瘤是以分层方式组织的,其中肿瘤生长由一小部分癌症干细胞(CSCs)或肿瘤起始细胞驱动。尽管这些细胞在整个肿瘤群体中只占一小部分,但它们是唯一能够启动和驱动肿瘤生长的细胞。新出现的证据表明,这些细胞对化疗和放疗也具有抗性,这引发了围绕癌症干细胞潜在临床适用性的诸多猜测和兴趣。

相似文献

1
Cancer stem cells in solid tumors: an overview.实体瘤中的癌症干细胞:综述
Semin Radiat Oncol. 2009 Apr;19(2):71-7. doi: 10.1016/j.semradonc.2008.11.001.
2
Cancer stem cells in solid tumors.实体瘤中的癌症干细胞。
Curr Opin Biotechnol. 2007 Oct;18(5):460-6. doi: 10.1016/j.copbio.2007.10.007.
3
Tumor initiating cancer stem cells from human breast cancer cell lines.源自人乳腺癌细胞系的肿瘤起始癌干细胞。
Int J Oncol. 2009 May;34(5):1449-53.
4
Mechanisms of Disease: cancer stem cells--targeting the evil twin.疾病机制:癌症干细胞——靶向“邪恶孪生子”
Nat Clin Pract Oncol. 2008 Jun;5(6):337-47. doi: 10.1038/ncponc1110. Epub 2008 Apr 22.
5
Recurrence cancer stem cells--made by cell fusion?复发性癌症干细胞——由细胞融合产生?
Med Hypotheses. 2009 Oct;73(4):542-7. doi: 10.1016/j.mehy.2009.05.044. Epub 2009 Jun 28.
6
Insights into the cell of origin in breast cancer and breast cancer stem cells.对乳腺癌起源细胞和乳腺癌干细胞的见解。
Asia Pac J Clin Oncol. 2010 Jun;6(2):89-97. doi: 10.1111/j.1743-7563.2010.01279.x.
7
Cancer stem cells: an approach to identify newer therapeutic targets.癌症干细胞:一种识别新型治疗靶点的方法。
J Stem Cells. 2009;4(2):123-31.
8
Isolation and establishment of human tumor stem cells.人肿瘤干细胞的分离与建立。
Methods Cell Biol. 2008;86:325-42. doi: 10.1016/S0091-679X(08)00015-0.
9
Cancer stem cells in solid tumors.实体瘤中的癌症干细胞。
Onkologie. 2009 Oct;32(10):605-9. doi: 10.1159/000232375. Epub 2009 Sep 14.
10
Is tumor growth sustained by rare cancer stem cells or dominant clones?肿瘤生长是由罕见的癌症干细胞还是优势克隆维持的?
Cancer Res. 2008 Jun 1;68(11):4018-21. doi: 10.1158/0008-5472.CAN-07-6334.

引用本文的文献

1
Efficacy of NAMPT Inhibitors in Pancreatic Cancer After Stratification by MAP17 (PDZK1IP1) Levels.根据MAP17(PDZK1IP1)水平分层后,烟酰胺磷酸核糖转移酶(NAMPT)抑制剂在胰腺癌中的疗效。
Cancers (Basel). 2025 Aug 5;17(15):2575. doi: 10.3390/cancers17152575.
2
MEG8 as an antagonistic pleiotropic mechanism in breast cancer.MEG8作为乳腺癌中的一种拮抗性多效性机制。
Cell Death Discov. 2024 Dec 20;10(1):509. doi: 10.1038/s41420-024-02272-0.
3
Myriad factors and pathways influencing tumor radiotherapy resistance.影响肿瘤放疗抵抗的众多因素和途径。
Open Life Sci. 2024 Nov 26;19(1):20220992. doi: 10.1515/biol-2022-0992. eCollection 2024.
4
GluOC promotes proliferation and metastasis of TNBC through the ROCK1 signaling pathway.葡萄糖氧化酶通过ROCK1信号通路促进三阴性乳腺癌的增殖和转移。
Cancer Cell Int. 2024 Jul 25;24(1):263. doi: 10.1186/s12935-024-03445-8.
5
Mechanisms of traditional Chinese medicine overcoming of radiotherapy resistance in breast cancer.中药克服乳腺癌放疗抵抗的机制
Front Oncol. 2024 Jun 27;14:1388750. doi: 10.3389/fonc.2024.1388750. eCollection 2024.
6
Cancer stem cells: a target for overcoming therapeutic resistance and relapse.癌症干细胞:克服治疗抗性和复发的靶点。
Cancer Biol Med. 2023 Dec 29;20(12):985-1020. doi: 10.20892/j.issn.2095-3941.2023.0333.
7
Molecular mechanisms of tumor resistance to radiotherapy.肿瘤放疗抵抗的分子机制。
Mol Cancer. 2023 Jun 15;22(1):96. doi: 10.1186/s12943-023-01801-2.
8
PTBP1 drives c-Myc-dependent gastric cancer progression and stemness.PTBP1 驱动 c-Myc 依赖性胃癌进展和干性。
Br J Cancer. 2023 Apr;128(6):1005-1018. doi: 10.1038/s41416-022-02118-5. Epub 2023 Jan 12.
9
Let-7a suppresses Ewing sarcoma CSCs' malignant phenotype via forming a positive feedback circuit with STAT3 and lin28.Let-7a通过与STAT3和lin28形成正反馈回路来抑制尤因肉瘤癌干细胞的恶性表型。
J Bone Oncol. 2021 Nov 30;31:100406. doi: 10.1016/j.jbo.2021.100406. eCollection 2021 Dec.
10
Functional Characterization of Brain Tumor-Initiating Cells and Establishment of GBM Preclinical Models that Incorporate Heterogeneity, Therapy, and Sex Differences.脑肿瘤起始细胞的功能特征分析及包含异质性、治疗和性别差异的 GBM 临床前模型的建立。
Mol Cancer Ther. 2021 Dec;20(12):2585-2597. doi: 10.1158/1535-7163.MCT-20-0547. Epub 2021 Aug 31.